Notably, this immunotherapy resistance may be partly explained by DDR1’s link to TMB and MSI, as positive correlations were observed between DDR1 expression and TMB in STAD and LUSC, and with MSI in STAD and LAML (Figure 2C,D). The gene discussed is DDR1; the disease is gastric adenocarcinoma.